The United Laboratories International Holdings Limited (HKG:3933)

Market Cap	23.98B
Revenue (ttm)	14.64B
Net Income (ttm)	2.83B
Shares Out	1.82B
EPS (ttm)	1.56
PE Ratio	8.47
Forward PE	6.58
Dividend	0.61 (4.60%)
Ex-Dividend Date	Jul 8, 2025

Volume	6,167,832
Average Volume	11,449,494
Open	12.90
Previous Close	12.94
Day's Range	12.86 - 13.46
52-Week Range	7.84 - 16.96
Beta	0.11
RSI	47.87
Earnings Date	May 29, 2025

About HKG:3933

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 17,000
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3933

Financial Performance

In 2024, HKG:3933's revenue was 13.76 billion, an increase of 0.14% compared to the previous year's 13.74 billion. Earnings were 2.66 billion, a decrease of -1.54%.

Financial numbers in CNY